NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT00201734 2016-09-23Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryOhio State University Comprehensive Cancer CenterPhase 1/2 Terminated57 enrolled 11 charts
NCT00368329 2012-07-16Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal CancerStanford UniversityPhase 1 Terminated4 enrolled